Head to head
Matthews International vs 3M
Side-by-side on the measures that matter, with a plain-English read. Full detail: MATW · MMM
MATW
Matthews International
19.39+0.10%
1-year price shape — -18% over the period
Quant Rating D · 21/100
vs
MMM
3M
177.99-0.27%
1-year price shape — +10% over the period
Quant Rating C · 51/100
1-year performance, rebased to 100
3M edges it on the scoreable measures. 3M has the highest Quant Rating (51); 3M has done best over the past year (+10%); 3M earns the most per share.
| MATW | MMM | |
|---|---|---|
| Snapshot | ||
| Sector | -- | -- |
| Last price | 19.39 | 177.99 |
| Change today | +0.10% | -0.27% |
| 1-year return | -18.1% | +9.7% |
| Market cap | $605.22M | $91.97B |
| 52-week range | 18.26 – 30.32 | 137.44 – 196.08 |
| Valuation | ||
| P/E (TTM) | -28.51 | 26.57 |
| P/E percentile, own 5-yr range | 32nd | 83rd |
| P/B | 1.30 | 22.28 |
| Dividend yield | 5.26% | 1.72% |
| Profitability & growth | ||
| EPS (TTM) | -0.68 | 6.00 |
| Net profit (TTM) | $-21.22M | $3.10B |
| Revenue (TTM) | $1.11B | $25.25B |
| Provider revenue period date | 2026-06-29 | 2026-09-29 |
| Revenue growth (YoY) | -29.6% | +1.0% |
| Gross margin | 36.6% | 39.5% |
| Operating margin | -3.6% | 20.1% |
| Net margin | -2.6% | 14.0% |
| Free cash flow (TTM) | $-81.97M | $2.68B |
| Provider cash-flow period date | 2026-06-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 92.5% | 77.0% |
| Insider activity (12mo) | 38 buy / 8 sell | 24 buy / 22 sell |
| Short interest (% of float) | 16.3% | 1.9% |
| Analyst consensus | 100% hold (1) | 36% buy / 55% hold / 9% sell (11) |
| Analyst price target | $24 (+24%) | $198 (+11%) |
| StockVane view | ||
| StockVane Quant Rating | D (21) | C (51) |
| Company | ||
| Employees | 5,500 | 60,500 |
| Founded | 1850 | 1929 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.